|
BIRC6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.91695573145989E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.09740003143111E-09 |
| Normal-vs-Stage2 |
1.71484E-05 |
| Normal-vs-Stage3 |
1.90739646299676E-11 |
| Normal-vs-Stage4 |
3.43730044427559E-10 |
| Stage1-vs-Stage2 |
9.112800E-01 |
| Stage1-vs-Stage3 |
6.998100E-02 |
| Stage1-vs-Stage4 |
1.860470E-02 |
| Stage2-vs-Stage3 |
2.530200E-01 |
| Stage2-vs-Stage4 |
1.218170E-01 |
| Stage3-vs-Stage4 |
4.956800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.08530978543331E-12 |
| Normal-vs-AfricanAmerican |
2.901900E-03 |
| Normal-vs-Asian |
1.87120000050278E-07 |
| Caucasian-vs-AfricanAmerican |
1.801010E-01 |
| Caucasian-vs-Asian |
8.008200E-01 |
| AfricanAmerican-vs-Asian |
1.792150E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.7912007694606E-11 |
| Normal-vs-Female |
7.47539807832709E-11 |
| Male-vs-Female |
3.364400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.66640000079477E-08 |
| Normal-vs-Age(41-60Yrs) |
1.380500158632E-10 |
| Normal-vs-Age(61-80Yrs) |
8.7051033048624E-11 |
| Normal-vs-Age(81-100Yrs) |
4.455500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.110800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.057580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.910200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.880800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.894000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.512200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.616800E-03 |
| Classical-VS-Follicular |
5.211800E-01 |
| Classical-VS-Other |
1.842410E-01 |
| Classical-VS-Normal |
3.80339981731481E-10 |
| Tall-VS-Follicular |
9.523700E-02 |
| Tall-VS-Other |
7.836400E-01 |
| Tall-VS-Normal |
1.32389998963589E-09 |
| Follicular-VS-Other |
3.661200E-01 |
| Follicular-VS-Normal |
3.38350000017584E-07 |
| Other-VS-Normal |
9.975500E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.19000048598639E-10 |
| Normal-vs-N1 |
2.65029997947863E-09 |
| N0-vs-N1 |
2.056800E-01 |
|
|
